Recombinant Human LILRB1 (C-mFc)

Description

EnkiLife provides the Recombinant Human LILRB1 (C-mFc) protein,aslo know as Leukocyte immunoglobulin-like receptor subfamily B member 1,LIR-1, Leukocyte immunoglobulin-like receptor 1,CD85 antigen-like family member J,Immunoglobulin-like transcript 2,ILT-2,Monocyte/macrophage immunoglobulin-like receptor 7,MIR-7,CD85j,LILRB1,ILT2,LIR1,MIR7, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Leukocyte immunoglobulin-like receptor subfamily B member 1 is produced by our Mammalian expression system and the target gene encoding Gly24-His458 is expressed with a mouse IgG1 Fc tag at the C-terminus.Accession:ADJ55949.1. Expression Host:Human Cells.Species:Human.Predicted Molecular Mass:73.6 KDa. Background:Leukocyte immunoglobulin-like receptor subfamily B member 1 (LILRB1) is known as CD85j. It is a receptor for class I MHC antigens, the protein can be recognized by a broad spectrum of HLA-A, HLA-B, HLA-C, HLA-G and HLA-F alleles. It expressed in B cells, monocytes and various dendritic cell (DC) subsets including myeloid, plasmacytoid and tolerogenic DCs. Diseases associated with LILRB1 include Alzheimers Disease 12 and Severe Pre-Eclampsia.